Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is a relatively newly described demyelinating disease of the central nervous system, without predominance by sex or racial category.1 It is characterized by serum MOG IgG1 autoantibodies whose pathogenetic role has not been proven yet. This evidence concerns the gene MOG and CNS demyelinating autoimmune disease.